The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats

被引:54
作者
Kozan, Ramazan [1 ]
Ayyildiz, Mustafa [1 ]
Agar, Erdal [1 ]
机构
[1] Ondokuz Mayis Univ, Fac Med, Dept Physiol, TR-55139 Samsun, Turkey
关键词
AM251; ACEA; Cannabinoids; Epileptiform activity; Penicillin; PENTYLENETETRAZOLE-INDUCED SEIZURE; CB1 RECEPTOR ANTAGONIST; NEURONAL CULTURE MODEL; CANNABINOID RECEPTOR; ACQUIRED EPILEPSY; MICE; ENDOCANNABINOIDS; CEREBELLUM; GABA; DELTA(9)-TETRAHYDROCANNABIVARIN;
D O I
10.1111/j.1528-1167.2009.02098.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P>Purpose: Several results support the conclusion that the cannabinoid system has a role in generation and cessation of epileptic seizures. The aim of this study was to evaluate the effects of intracerebroventricular AM-251 [N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide], a CB1-receptor antagonist, and ACEA (arachidonyl-2-chloroethylamide), a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats. Methods: In the first set of experiments, 30 min after penicillin injection, AM-251, at doses of 0.125, 0.25, 0.5, and 1 mu g, was administered intracerebroventricularly (i.c.v.). In the second set of experiments, 30 min after penicillin injection, ACEA, at doses of 2.5, 5, 7.5, and 15 mu g (i.c.v.), was administered. In the third set of experiments, AM-251, at doses of 0.125 and 0.25 mu g (i.c.v.), was administered 10 min before ACEA (7.5 mu g, i.c.v.) injection. Results: ACEA, at a dose of 7.5 mu g, significantly decreased the frequency of penicillin-induced epileptiform activity without changing the amplitude. ACEA, at doses of 2.5, 5, and 15 mu g, had no impact on either frequency or amplitude of epileptiform activity. AM-251, at doses of 0.25 and 0.50 mu g, significantly increased the frequency of epileptiform activity. AM-251, at a dose of 0.25 mu g (i.c.v.), was the most effective in changing the frequency of penicillin-induced epileptiform activity, and it also caused status epilepticus-like activity. AM-251, at doses of 0.125 and 0.25 mu g, 10 min before ACEA (7.5 mu g), reversed the anticonvulsant action of ACEA. Discussion: The results of the present study provide electrophysiologic evidence for the role of CB1 receptors in regulating the frequency of epileptiform activity in the model of penicillin-induced epilepsy. To elucidate the precise mechanism of cannabinoid action in the brain during seizure, more advanced electrophysiologic and neurochemical studies are required.
引用
收藏
页码:1760 / 1767
页数:8
相关论文
共 42 条
[11]   Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy [J].
Deshpande, Laxmikant S. ;
Sombati, Sompong ;
Blair, Robert E. ;
Carter, Dawn S. ;
Martin, Billy R. ;
DeLorenzo, Robert J. .
NEUROSCIENCE LETTERS, 2007, 411 (01) :11-16
[12]  
DICHTER MA, 1994, HARRISONS PRINCIPLES, P2223
[13]   Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy [J].
Falenski, K. W. ;
Blair, R. E. ;
Sim-Selley, L. J. ;
Martin, B. R. ;
DeLorenzo, R. J. .
NEUROSCIENCE, 2007, 146 (03) :1232-1244
[14]   Role of endogenous cannabinoids in synaptic signaling [J].
Freund, TF ;
Katona, I ;
Piomelli, D .
PHYSIOLOGICAL REVIEWS, 2003, 83 (03) :1017-1066
[15]   Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice [J].
Gholizadeh, Shervin ;
Shafaroodi, Hamed ;
GhaseMi, Mehdi ;
Bahremand, Arash ;
Sharifzadeh, Mohammad ;
Dehpour, Ahmad Reza .
NEUROPHARMACOLOGY, 2007, 53 (06) :763-770
[16]   Alcohol and marijuana: Effects on epilepsy and use by patients with epilepsy [J].
Gordon, E ;
Devinsky, O .
EPILEPSIA, 2001, 42 (10) :1266-1272
[17]   Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents [J].
Griebel, G ;
Stemmelin, J ;
Scatton, B .
BIOLOGICAL PSYCHIATRY, 2005, 57 (03) :261-267
[18]  
Hayase T, 2001, Nihon Arukoru Yakubutsu Igakkai Zasshi, V36, P596
[19]  
Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427
[20]  
Hoffman AF, 2000, J NEUROSCI, V20, P2470